Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation

Title: LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation
Authors: Hoeh, Alexandra E; Chang, Jui-Hsien; Mueller, Ronja S; Basche, Mark; Fantin, Alessandro; Sepetis, Anastasios; De Rossi, Giulia; Dritsoula, Athina; Ali, Robin R; Turowski, Patric; Moss, Stephen E; Greenwood, John
Contributors: A.E. Hoeh; J. Chang; R.S. Mueller; M. Basche; A. Fantin; A. Sepeti; G. De Rossi; A. Dritsoula; R.R. Ali; P. Turowski; S.E. Mo; J. Greenwood
Publisher Information: MDPI
Publication Year: 2025
Collection: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
Subject Terms: angiogenesi; blood vessel maturation; blood–retinal barrier; leucine-rich alpha-2-glycoprotein-1 (LRG1); pericyte; Settore BIOS-06/A - Fisiologia; Settore BIOS-10/A - Biologia cellulare e applicata
Description: Upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) contributes to aberrant neovascularization in many different diseases. In contrast, LRG1 is not involved in developmental angiogenesis. Here, we investigated the vasculopathic properties of LRG1 by examining its effect on developing retinal blood vessels. By injecting recombinant protein or an expression vector into the mouse retina during vascular development, we showed that exogenous LRG1 reduces pericyte coverage and NG2 expression. It leads to diminished collagen IV sheathing, fewer adhesion and gap junctions, and reduced vessel calibre and vascular density. Moreover, in mouse retinae containing exogenous LRG1, the developing blood–retinal barrier remains more permeable with significantly higher numbers of transcytotic vesicles present in microvascular endothelial cells. These results reveal that exogeneous LRG1 is sufficient to interfere with the maturation of developing retinal vessels and drive vessel development towards a dysfunctional phenotype. These observations deliver further evidence that LRG1 is an angiopathic factor and highlight the therapeutic potential of blocking LRG1 in diseases characterized by pathogenic angiogenesis or vascular remodelling.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/40277918; info:eu-repo/semantics/altIdentifier/wos/WOS:001474387700001; volume:14; issue:8; firstpage:1; lastpage:21; numberofpages:21; journal:CELLS; https://hdl.handle.net/2434/1163198
DOI: 10.3390/cells14080593
Availability: https://hdl.handle.net/2434/1163198; https://doi.org/10.3390/cells14080593
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.83788B80
Database: BASE